41 Highland Avenue, Winchester, MA, 01890 · (781) 729-9000
Beds
183
FY 2025
Star rating
3 of 5
Patient survey: 3 of 5
Net patient revenue
$366.0M
FY 2025
Net income
$44.9M
Patient care margin 4.0%
Discharges
12,276
Occupancy 75.9%
Clinicians
1,294
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $366.0M | $351.2M | 4.0% | $44.9M | 12,276 | $8.2M | 34.9% | 3.6% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 7.2% | US median 8.5% |
| Death rate for heart attack patients | 11% | US median 11.8% |
| Death rate for heart failure patients | 10% | US median 11% |
| Hospital-wide death rate within 30 days | 3.3% | US median 3.9% |
| Death rate for pneumonia patients | 11.4% | US median 15.2% |
| Death rate for stroke patients | 8.1% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $368.8M | $367.0M | 0.5% | $29.1M | 13,264 | $6.2M | 32.7% | 3.3% |
| 2023 | $338.6M | $343.8M | -1.6% | $13.5M | 12,003 | $5.8M | 32.6% | 4.6% |
| 2022 | $314.9M | $327.2M | -3.9% | $7.1M | 12,225 | $5.9M | 34.8% | 4.2% |
| 2021 | $300.8M | $296.4M | 1.5% | $19.9M | 12,223 | $5.1M | 31.9% | 3.9% |
| 2020 | $261.4M | $278.1M | -6.4% | $19.4M | 11,379 | $5.4M | 33.1% | 3.4% |
| Readmission rate for COPD | 19.9% | US median 19.8% |
| Readmission rate for heart failure | 23.3% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.9% | US median 5.8% |
| Readmission rate for pneumonia | 18.2% | US median 17.2% |
| Complications after hip or knee replacement | 3.1% | US median 4.1% |
| Serious complications (patient safety composite) | 0.81 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.68 | US median 0.28 |
| Central line bloodstream infections (ratio to expected) | 0.62 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 1.15 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 1.26 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.00 | US median 0.40 · better |
| Doctors always communicated well | 78% | US median 79% |
| Nurses always communicated well | 83% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 42% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 70% | US median 72% |
| Room and bathroom always clean | 66% | US median 73% |
| Patients who would definitely recommend the hospital | 75% | US median 71% |
| Patients who left the emergency department before being seen | 3% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 233 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 13% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 52% | US median 65% |
| Healthcare workers given the flu vaccine | 100% | US median 79% |
| 209 |
| $25,568.17 |
| $11,782.72 |
| $12,667.88 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 158 | $19,957.26 | $9,109.73 | $9,867.73 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 127 | $12,759.18 | $4,917.98 | $5,662.18 |
| DRG 683 RENAL FAILURE WITH CC | 92 | $14,544.62 | $5,888.33 | $6,629.69 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 86 | $14,733.62 | $8,033.98 | $8,838.11 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 84 | $17,286.63 | $8,618.26 | $9,973.97 |
| DRG 603 CELLULITIS WITHOUT MCC | 83 | $10,612.11 | $5,602.42 | $6,446.25 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 77 | $12,750.87 | $5,172.34 | $5,985.69 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 75 | $24,069.40 | $10,882.67 | $12,400.10 |
| DRG 682 RENAL FAILURE WITH MCC | 74 | $19,830.42 | $10,233.88 | $11,457.18 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 73 | $23,421.77 | $11,516.19 | $13,076.55 |
| DRG 194 SIMPLE PNEUMONIA AND PLEURISY WITH CC | 68 | $12,673.99 | $4,986.40 | $5,880.23 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 64 | $31,714.17 | $12,763.94 | $14,289.25 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5115 Level 5 Musculoskeletal Procedures | 283 | 278 | $12,389.53 | $10,771.69 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 247 | 235 | $1,370.27 | $1,219.56 |
| APC 8011 Comprehensive Observation Services | 177 | 173 | $2,275.74 | $2,090.36 |
| APC 5431 Level 1 Nerve Procedures | 151 | 137 | $1,628.83 | $1,406.61 |
| APC 5302 Level 2 Upper GI Procedures | 148 | 132 | $1,611.37 | $1,444.50 |
| APC 5112 Level 2 Musculoskeletal Procedures | 146 | 140 | $1,349.96 | $1,196.16 |
| APC 5361 Level 1 Laparoscopy and Related Services | 131 | 129 | $4,824.12 | $4,357.80 |
| APC 5375 Level 5 Urology and Related Services | 116 | 107 | $4,427.57 | $3,917.51 |
| APC 5374 Level 4 Urology and Related Services | 104 | 92 | $2,925.65 | $2,629.24 |
| APC 5114 Level 4 Musculoskeletal Procedures | 104 | 103 | $6,003.84 | $5,338.75 |
| APC 5113 Level 3 Musculoskeletal Procedures | 85 | 85 | $2,737.11 | $2,373.24 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 71 | 71 | $2,431.40 | $2,141.49 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Aesculap, Inc. | 2 | $3,635 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Winchester Hospital is a nonprofit short-term acute care hospital in Winchester, MA with 183 beds, part of Beth Israel Lahey Health and a 3-star overall rating.
Winchester Hospital in Winchester, MA has 183 beds (fiscal year 2025 cost report); 189 beds are certified for Medicare. It discharged 12,276 inpatients that year, with 75.9% of its beds in use on average.
In fiscal year 2025 (ending 2025-09-30), Winchester Hospital reported net patient revenue of $366.0M and operating expenses of $351.2M, a margin on patient care of 4.0%. After other income and expenses its net income was $44.9M (11.3% of revenue), so it made a profit that year.
Winchester Hospital is part of Beth Israel Lahey Health, a health system with 11 hospitals based in Cambridge, MA. It is a nonprofit hospital.
Winchester Hospital has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey. 1 death rate measures are better and 0 worse than the national rate.
Yes, Winchester Hospital provides emergency services.
1,294 Medicare clinicians list Winchester Hospital as a hospital they work at, most often in Nurse Practitioner, Internal Medicine, Physician Assistant.
In 2024, Winchester Hospital had 3,636 Medicare inpatient stays in 89 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 327 stays; Medicare paid $13,609.15 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $3,635 in payments to Winchester Hospital as a teaching hospital ($3,635 general and - for research) from 1 companies.